275 related articles for article (PubMed ID: 28522669)
1. Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.
Vollherbst DF; Sommer CM; Ulfert C; Pfaff J; Bendszus M; Möhlenbruch MA
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1377-1382. PubMed ID: 28522669
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.
Vollherbst DF; Otto R; von Deimling A; Pfaff J; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
J Neurointerv Surg; 2018 Mar; 10(3):268-274. PubMed ID: 28689184
[TBL] [Abstract][Full Text] [Related]
3. Imaging Artifacts of Nonadhesive Liquid Embolic Agents in Conventional and Cone-beam CT in a Novel in Vitro AVM Model.
Schmitt N; Floca RO; Paech D; El Shafie RA; Neuberger U; Bendszus M; Möhlenbruch MA; Vollherbst DF
Clin Neuroradiol; 2021 Dec; 31(4):1141-1148. PubMed ID: 33852036
[TBL] [Abstract][Full Text] [Related]
4. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
Lamin S; Chew HS; Chavda S; Thomas A; Piano M; Quilici L; Pero G; Holtmannspolter M; Cronqvist ME; Casasco A; Guimaraens L; Paul L; Gil Garcia A; Aleu A; Chapot R
AJNR Am J Neuroradiol; 2017 Jan; 38(1):127-131. PubMed ID: 27932510
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment approach to cerebral arteriovenous malformation in pediatric patients: stereotactic radiosurgery to partially Onyx-embolized AVM.
Umansky D; Corn BW; Strauss I; Shtraus N; Constantini S; Frolov V; Maimon S; Kanner AA
Childs Nerv Syst; 2018 Nov; 34(11):2269-2274. PubMed ID: 29882061
[TBL] [Abstract][Full Text] [Related]
6. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.
Koçer N; Hanımoğlu H; Batur Ş; Kandemirli SG; Kızılkılıç O; Sanus Z; Öz B; Işlak C; Kaynar MY
Diagn Interv Radiol; 2016; 22(2):184-9. PubMed ID: 26782157
[TBL] [Abstract][Full Text] [Related]
7. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances.
Natarajan SK; Ghodke B; Britz GW; Born DE; Sekhar LN
Neurosurgery; 2008 Jun; 62(6):1213-25; discussion 1225-6. PubMed ID: 18824988
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study.
Lee CC; Chen CJ; Ball B; Schlesinger D; Xu Z; Yen CP; Sheehan J
J Neurosurg; 2015 Jul; 123(1):126-35. PubMed ID: 25658780
[TBL] [Abstract][Full Text] [Related]
9. Intermixed Dimethyl-Sulfoxide-Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment.
Sirakov A; Minkin K; Sirakov S
AJNR Am J Neuroradiol; 2020 Apr; 41(4):681-686. PubMed ID: 32165357
[TBL] [Abstract][Full Text] [Related]
10. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.
Vollherbst DF; Chapot R; Bendszus M; Möhlenbruch MA
Clin Neuroradiol; 2022 Mar; 32(1):25-38. PubMed ID: 34324005
[TBL] [Abstract][Full Text] [Related]
11. Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article.
Mamalui-Hunter M; Jiang T; Rich KM; Derdeyn CP; Drzymala RE
J Neurosurg; 2011 Aug; 115(2):364-70. PubMed ID: 21495824
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
Duffner F; Ritz R; Bornemann A; Freudenstein D; Wiendl H; Siekmann R
Clin Neuropathol; 2002; 21(1):13-7. PubMed ID: 11846039
[TBL] [Abstract][Full Text] [Related]
13. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article.
Loh Y; Duckwiler GR;
J Neurosurg; 2010 Oct; 113(4):733-41. PubMed ID: 20433277
[TBL] [Abstract][Full Text] [Related]
14. Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience.
Xu H; Wang L; Guan S; Li D; Quan T
Neuroradiology; 2019 Apr; 61(4):471-478. PubMed ID: 30712140
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.
Leyon JJ; Chavda S; Thomas A; Lamin S
J Neurointerv Surg; 2016 Jun; 8(6):596-602. PubMed ID: 25994938
[TBL] [Abstract][Full Text] [Related]
16. Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL
Giurazza F; Corvino F; Silvestre M; Cangiano G; De Magistris G; Cavaglià E; Amodio F; Niola R
Radiol Med; 2021 Mar; 126(3):474-483. PubMed ID: 32889705
[TBL] [Abstract][Full Text] [Related]
17. Rupture of a detachable-tip microcatheter away from the detachment zone during Onyx 18 embolization of an arteriovenous malformation and management of the complication.
Cortese J; Coskun O; Di Maria F; Pizzuto S; Rodesch G; Consoli A
J Neurointerv Surg; 2022 May; 14(5):. PubMed ID: 35074897
[TBL] [Abstract][Full Text] [Related]
18. Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model.
Vollherbst DF; Otto R; Do T; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
Interv Neuroradiol; 2018 Dec; 24(6):693-701. PubMed ID: 29973083
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a New Version of the Liquid Embolic Agent PHIL with Extra-Low-Viscosity in an Endovascular Embolization Model.
Vollherbst DF; Otto R; Hantz M; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1696-1702. PubMed ID: 30093480
[TBL] [Abstract][Full Text] [Related]
20. Onyx resorbtion with AVM recanalization after complete AVM obliteration.
Bauer AM; Bain MD; Rasmussen PA
Interv Neuroradiol; 2015 Jun; 21(3):351-6. PubMed ID: 26015523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
